Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2024

Cost and committee reports

Official records Congress.gov attaches to H.R. 8247.

• Constitutional authority statementThe sponsor’s statement of where the Constitution gives Congress the power to pass this bill. Statement by Ms. BROWN, as printed in the Congressional Record (Vol. 170, No. 78, May 6, 2024, Page H2875):
  Article I Section VIII The single subject of this legislation is: To improve the livelihoods of women diagnosed with uterine fibrosis through detection, intervention, and treatment
  Source: Congress.gov, Congressional Record May 6, 2024 ↗

  Evidence

  Field in the Congress.gov record

  constitutionalAuthorityStatementText

  Statement length

  180 characters

  Congress.gov bill record

  H.R. 8247, 118th Congress

  Congress.gov API record

  https://api.congress.gov/v3/bill/118/hr/8247

  Record last updated by Congress.gov

  November 23, 2024

  PORKER copy retrieved

  September 14, 2026

  Stored copy, SHA-256 of the file

  09e0f3fa68c7a4877ad719fe96a8b5ef922bc537985e14def32b50b9222c5417

  PORKER shows the statement exactly as printed, with the page markup removed. It is the sponsor’s claim; it is not a legal finding.

Congress.gov’s record for this bill does not list a CBO cost estimate or a committee report (as of November 23, 2024). Not every bill gets one.

From the Congress.gov bill record for H.R. 8247, last updated November 23, 2024. PORKER’s copy was retrieved September 14, 2026 and is refreshed nightly. Open “Evidence” on any line for the record, field and file fingerprint.